0001104659-25-002053.txt : 20250108
0001104659-25-002053.hdr.sgml : 20250108
20250108163159
ACCESSION NUMBER: 0001104659-25-002053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20250106
FILED AS OF DATE: 20250108
DATE AS OF CHANGE: 20250108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sailer Carl
CENTRAL INDEX KEY: 0001854182
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40536
FILM NUMBER: 25518924
MAIL ADDRESS:
STREET 1: 4 GREENBRIAR LANE
CITY: MONTVALE
STATE: NJ
ZIP: 07645
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001736243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
BUSINESS PHONE: 917-533-1469
MAIL ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
FORMER COMPANY:
FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20180402
4
1
tm252665-5_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2025-01-06
0
0001736243
Acurx Pharmaceuticals, Inc.
ACXP
0001854182
Sailer Carl
C/O ACURX PHARMACEUTICALS, INC.,
259 LIBERTY AVENUE
STATEN ISLAND
NY
10305
1
0
0
0
0
Common Stock
2025-01-06
4
P
0
24631
1.015
A
137183
D
Common Stock
5000
I
By Spouse
Warrants for Common Stock
0.90
2025-01-06
4
P
0
24631
0
A
2025-01-07
2030-01-07
Common Stock
24631
24631
D
Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.
/s/ Kostantinos Skordalos, Power of Attorney For: Carl V. Sailer
2025-01-08